Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 2;18(1):514.
doi: 10.1186/s12885-018-4249-1.

CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma

Affiliations

CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma

Yue Chen et al. BMC Cancer. .

Abstract

Background: Tongue squamous cell carcinoma (TSCC) is one of the most common malignancies of oral squamous cell carcinomas. Cellular retinol binding protein-1 (CRBP-1) as a carrier protein transports retinol from the liver storage site to peripheral tissue. Up-regulated expression of CRBP-1 is associated with some tumor types such as prostate cancer, breast cancer and ovarian cancer as reported, but its role in TSCC remains uncertain.

Methods: In this study, an integrated bioinformatics analysis based on the multiple cancer microarray data sets available from Oncomine database was conducted to view the differential expression of CRBP-1 between TSCC and the adjacent non-tumorous tissues. Quantitative real-time polymerase chain reaction (qRT-PCR), western blotting (WB) and immunohistochemical (IHC) assays were performed to investigate CRBP-1 expression in 101 paraffin-embeded TSCC tissues and 48 pairs of freshly frozen tissues. Kaplan-Meier curve and univariate and multivariate Cox-regression analysis were used to estimate the association between CRBP-1 expression and patients' prognosis. Then western blotting, MTT, transwell migration and invasion assays were performed in TSCC cell lines to investigate the effects of CRBP-1 on cellular proliferation and invasion.

Results: Compared with the matched adjacent non-tumorous tissues, the expression of CRBP-1 was significantly up-regulated in TSCC tissues, which correlated with the differentiation state (P = 0.003), N classification (P = 0.048), the clinical stage (P = 0.048) and death (P = 0.001). The Kaplan-Meier curve showed that TSCC patients with higher CRBP-1 expression levels had lower overall survival rates than those with lower CRBP-1 expression levels. A univariate and multivariate analysis demonstrated that CRBP-1 was an independent prognostic factor (P < 0.05). Furthermore, we knocked down CRBP-1 expression and observed that TSCC cell proliferation and invasion in vitro were significantly blocked, as determined by MTT and transwell assays.

Conclusions: Up-regulated expression of CRBP-1 is associated with poor prognosis in TSCC, so it might potentially serve as an additional prognostic marker, and the inhibition of CRBP-1 might provide new therapeutic approaches for TSCC.

Keywords: CRBP-1; Expression; Invasion; Knockdown; Prognosis; Proliferation; Tongue squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The Ethics Committee of the Sun Yat-sen University Cancer Center approved all the tumor specimens used for this study. All the participating patients in this study have signed the informed consent forms.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Expression of CRBP-1 mRNA in human TSCC tissues and matched adjacent non-tumorous tissues. a The relative CRBP-1 mRNA expression levels significantly increased in TSCC tissues (T) compared with those of the matched adjacent non-tumorous tissues (ANT)(n = 48, P < 0.001). The mRNA expression level of CRBP-1 was measured by qRT-PCR. b CRBP-1 is overexpressed in human TSCC tissues(T) than the adjacent normal tissues(N) in multiple cancer microarray data sets available from Oncomine. c CRBP-1 is overexpressed in HNSCC tissues(T) than the adjacent normal tissues(N) in multiple cancer microarray data sets available from Oncomine. Data is presented as mean ± S.D. **P < 0.01 versus the corresponding control groups
Fig. 2
Fig. 2
Expression of CRBP-1 protein in human TSCC tissues and matched adjacent non-tumorous tissues. a The relative CRBP-1 protein expression in 7 pairs of TSCC tissues (T) and the matched adjacent non-tumorous tissues (ANT). GAPDH was measured as the loading control. b Immunohistochemical staining of CRBP-1 in three pairs of representative TSCC tissues (T) and the adjacent non-tumorous tissues (ANT)(× 100)
Fig. 3
Fig. 3
Correlation between CRBP-1 expression in TSCC and clinicopathological features. a Increased expression of CRBP-1 in advanced stages of TSCC. Representative IHC analysis of CRBP-1 expression in TSCC specimens (T) and the matched adjacent non-tumorous tissues (ANT) of different clinical stages. b CRBP-1 expression in TSCC tissues with different differentiation states
Fig. 4
Fig. 4
Kaplan-Meier survival curves for TSCC patients with high CRBP-1 expression (red line) versus low CRBP-1 expression (blue line). The overall survival of patients with high or low CRBP-1 expression
Fig. 5
Fig. 5
Knockdown of CBRP-1 reduced the cell proliferation and invasion ability in CAL-27 and SCC-25 cells. a The relative expression levels of CRBP-1 in TSCC cell lines were evaluated by western blotting. b Immunoblotting analysis of CRBP-1 in CAL-27 and SCC-25 cells transduced with two specific shRNA. c Growth curves of CAL-27 and SCC-25 cells with knockdown of CRBP-1. Scramble (sc): the lentiviral vector with a scrambled sequence that does not target any mRNA. d Images (upper panel) and quantification (lower panel) of invaded TSCC cells treated with melatonin for 24 h were analyzed in a transwell matrix penetration assay. Scar bar: 100 μm. Data is presented as mean ± S.D. **P < 0.01 versus the corresponding control groups

Similar articles

Cited by

References

    1. Qiu K, Huang Z, Huang Z, et al. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma. Arch Oral Biol. 2016;66:92–97. doi: 10.1016/j.archoralbio.2016.02.013. - DOI - PubMed
    1. Tsushima N, Sakashita T, Homma A, et al. The role of prophylactic neck dissection and tumor thickness evaluation for patients with cN0 tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2016;273:1–6. doi: 10.1007/s00405-016-4077-3. - DOI - PubMed
    1. Zhang T, Liang L, Liu X, et al. TGFβ1-Smad3-Jagged1-Notch1–slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma. J Oral Pathol Med. 2016;45(7):486–493. doi: 10.1111/jop.12406. - DOI - PubMed
    1. Lao XM, Liang YJ, Su YX, et al. Distribution and significance of interstitial fibrosis and stroma-infiltrating B cells in tongue squamous cell carcinoma. Oncol Lett. 2016;11(3):2027–2034. doi: 10.3892/ol.2016.4184. - DOI - PMC - PubMed
    1. Adeel M, Suhail A. Squamous cell carcinoma of oral tongue in young patients – a 10 years tertiary care experience. J Pak Med Assoc. 2016;66:155–158. - PubMed

Substances

LinkOut - more resources